Related references
Note: Only part of the references are listed.Mutations in PIK3R1 Cause SHORT Syndrome
David A. Dyment et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2013)
Spinal Muscular Atrophy Associated with Progressive Myoclonic Epilepsy Is Caused by Mutations in ASAH1
Jie Zhou et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2012)
Acid Ceramidase Expression Modulates the Sensitivity of A375 Melanoma Cells to Dacarbazine
Carmen Bedia et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
PROGRESSIVE MYOCLONUS EPILEPSY
M. Koskiniemi et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
A simple fluorogenic method for determination of acid ceramidase activity and diagnosis of Farber disease
Carmen Bedia et al.
JOURNAL OF LIPID RESEARCH (2010)
Human Splicing Finder: an online bioinformatics tool to predict splicing signals
Francois-Olivier Desmet et al.
NUCLEIC ACIDS RESEARCH (2009)
Acid ceramidase and human disease
Jae-Ho Park et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2006)
Spinal muscular atrophy and progressive myoclonic epilepsy: one case report and characteristics of the epileptic syndrome
P Striano et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2004)
Spinal muscular atrophy with progressive myoclonic epilepsy:: Report of new cases and review of the literature
G Haliloglu et al.
NEUROPEDIATRICS (2002)
Determination of ceramides and diglycerides by the diglyceride kinase assay
A Bielawska et al.
ANALYTICAL BIOCHEMISTRY (2001)
Molecular analysis of acid ceramidase deficiency in patients with Farber disease
J Bar et al.
HUMAN MUTATION (2001)
Share Paper
